HPRA to raise fees to drug companies by 8%

The medicines regulator is proposing to increase its fees to veterinary and pharma companies by 8 per cent.

In submissions to the Health Products Regulatory Authority (HPRA), representative groups warned that their members already faced increased costs due to Brexit and the implementation of the Falsified Medicines Directive.

In a statement, the Irish Pharmaceutical Healthcare Association (IPHA) said: “We consider the fees increase part of the overall Brexit cost which is being passed ...